These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32093917)

  • 1. In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure.
    Abumoawad A; Saad A; Ferguson CM; Eirin A; Herrmann SM; Hickson LJ; Goksu BB; Bendel E; Misra S; Glockner J; Dietz AB; Lerman LO; Textor SC
    Kidney Int; 2020 Apr; 97(4):793-804. PubMed ID: 32093917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.
    Saad A; Dietz AB; Herrmann SMS; Hickson LJ; Glockner JF; McKusick MA; Misra S; Bjarnason H; Armstrong AS; Gastineau DA; Lerman LO; Textor SC
    J Am Soc Nephrol; 2017 Sep; 28(9):2777-2785. PubMed ID: 28461553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease.
    Herrmann SM; Saad A; Eirin A; Woollard J; Tang H; McKusick MA; Misra S; Glockner JF; Lerman LO; Textor SC
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):458-69. PubMed ID: 26787779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.
    Chen XJ; Zhang X; Jiang K; Krier JD; Zhu X; Conley S; Lerman A; Lerman LO
    J Cell Physiol; 2020 Dec; 235(12):9806-9818. PubMed ID: 32430932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue hypoxia, inflammation, and loss of glomerular filtration rate in human atherosclerotic renovascular disease.
    Abumoawad A; Saad A; Ferguson CM; Eirin A; Woollard JR; Herrmann SM; Hickson LJ; Bendel EC; Misra S; Glockner J; Lerman LO; Textor SC
    Kidney Int; 2019 Apr; 95(4):948-957. PubMed ID: 30904069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate.
    Saad A; Herrmann SM; Crane J; Glockner JF; McKusick MA; Misra S; Eirin A; Ebrahimi B; Lerman LO; Textor SC
    Circ Cardiovasc Interv; 2013 Aug; 6(4):428-35. PubMed ID: 23899868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peristenotic Collateral Circulation in Atherosclerotic Renovascular Disease: Association With Kidney Function and Response to Treatment.
    Afarideh M; Zhang X; Ferguson CM; Glockner JF; Lerman A; Textor SC; Lerman LO
    Hypertension; 2020 Aug; 76(2):497-505. PubMed ID: 32507040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis.
    Eirin A; Zhu XY; Krier JD; Tang H; Jordan KL; Grande JP; Lerman A; Textor SC; Lerman LO
    Stem Cells; 2012 May; 30(5):1030-41. PubMed ID: 22290832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
    Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
    Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.
    Eirin A; Zhu XY; Puranik AS; Tang H; McGurren KA; van Wijnen AJ; Lerman A; Lerman LO
    Kidney Int; 2017 Jul; 92(1):114-124. PubMed ID: 28242034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.
    Urbieta-Caceres VH; Zhu XY; Jordan KL; Tang H; Textor K; Lerman A; Lerman LO
    Atherosclerosis; 2012 Apr; 221(2):350-8. PubMed ID: 22341593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine.
    Eirin A; Zhu XY; Jonnada S; Lerman A; van Wijnen AJ; Lerman LO
    Cell Transplant; 2018 Jul; 27(7):1080-1095. PubMed ID: 29954220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease.
    Eirin A; Ebrahimi B; Zhang X; Zhu XY; Woollard JR; He Q; Textor SC; Lerman A; Lerman LO
    Cardiovasc Res; 2014 Sep; 103(4):461-72. PubMed ID: 24947415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and injury signals released from the post-stenotic human kidney.
    Eirin A; Gloviczki ML; Tang H; Gössl M; Jordan KL; Woollard JR; Lerman A; Grande JP; Textor SC; Lerman LO
    Eur Heart J; 2013 Feb; 34(7):540-548a. PubMed ID: 22771675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles Elicit Better Preservation of the Intra-Renal Microvasculature Than Renal Revascularization in Pigs with Renovascular Disease.
    Ferguson CM; Farahani RA; Zhu XY; Tang H; Jordan KL; Saadiq IM; Lerman A; Lerman LO; Eirin A
    Cells; 2021 Mar; 10(4):. PubMed ID: 33807246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease.
    Zhang L; Zhu XY; Zhao Y; Eirin A; Liu L; Ferguson CM; Tang H; Lerman A; Lerman LO
    Basic Res Cardiol; 2020 Jan; 115(2):16. PubMed ID: 31938859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms.
    Zhu XY; Urbieta-Caceres V; Krier JD; Textor SC; Lerman A; Lerman LO
    Stem Cells; 2013 Jan; 31(1):117-25. PubMed ID: 23097349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mesenchymal stem cells in renovascular disease of preclinical and clinical studies: a systematic review and meta-analysis.
    Wang HS; Yi MY; Wu X; Liu Q; Deng YH; Wu T; Wang L; Kang YX; Luo XQ; Yan P; Wang M; Duan SB
    Sci Rep; 2022 Oct; 12(1):18080. PubMed ID: 36302933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats.
    Oliveira-Sales EB; Varela VA; Maquigussa E; Borges FT; Shimoura CG; Gomes G; Campos RR; Boim MA
    Clin Exp Hypertens; 2016; 38(7):586-593. PubMed ID: 27649588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis.
    Eirin A; Ebrahimi B; Zhang X; Zhu XY; Tang H; Crane JA; Lerman A; Textor SC; Lerman LO
    Circ Cardiovasc Interv; 2012 Oct; 5(5):720-8. PubMed ID: 23048054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.